Even as the Trump administration works to implement its “most favored nation” pricing system, the U.S. government continues to advance efforts to negotiate Medicare drug prices as enabled by the Inflation Reduction Act.
Related Posts
Microplastics Are Here, There, Everywhere – The Health Care Blog
By KIM BELLARD Vaccine experts are going rogue in response to RFK Jr’s attacks on vaccine safety. Health insurers promise – honest…this time – to […]
HIMSS25: Collaboration Is Central to Healthcare Innovation
Becoming Agile and Listening to Clinicians After Wolf, Samsung Medical Center President and CEO Dr. Seung Woo Park discussed the history and growth of […]
How Predictive Analytics Is Improving Perioperative Efficiency
Predictive analytics is reshaping how hospital surgical teams manage their scheduling. Sam Davis Jr., D.N.P., M.H.A., R.N., associate vice president of perioperative and interventional services […]